A 57-Year-Old Man with T2DM, Obesity, Hypertension, CKD, and a Family History of ASCVD

Through this patient case, you’ll gain valuable knowledge on how to avoid therapeutic inertia when treating people with type 2 diabetes mellitus (T2DM) and comorbid conditions. Come away with strategies for creating treatment plans that fully consider your patients’ needs.

Learning Objectives

  • Apply guideline-directed treatment to overcome therapeutic inertia in people with T2DM and comorbid conditions
  • Individualize treatment in people with T2DM based on patient characteristics, health goals, and preferences

Additional Information

Partner: 
Pri-Med
Course summary
Available credit: 
  • 0.45 AANP Contact Hours
  • 0.50 AMA PRA Category 1 Credit™
Course opens: 
06/11/2023
Course expires: 
06/12/2024
Rating: 
0

Tina K. Thethi, MD, MPH

Associate Investigator and Endocrinologist
AdventHealth Translational Research Institute
Orlando, FL

Pamela Kushner, MD, FAAFP

Clinical Professor, UC Irvine Medical Center
Director, Kushner Wellness Center
Orange, CA

Disclosures

The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.

Tina K. Thethi, MD, MPH: Advisor for Bayer, Consultant and Researcher for Novo Nordisk.

Pamela Kushner, MD, FAAFP: Speaker for Boehringer Ingelheim, Lilly, AstraZeneca, Bayer, Pfizer. Advisor for Astellas, Boehringer Ingelheim, Lilly, Novo Nordisk, Abbott, Intuity. Consultant for AstraZeneca, Bayer, Phathom. Stockholder for Lilly and AstraZeneca.

Alissa Scott, BA (Planner): Stock Holder, Merck.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

AMA PRA Category 1 Credits™

Accreditation Statement

Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP

Accreditation Statement

Pri-Med Institute is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider Number 040308.

Designation Statement

This activity is approved for 0.45 contact hours of continuing education, which includes 0.00 hours of pharmacology.

MOC Credit Information

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

Available Credit

  • 0.45 AANP Contact Hours
  • 0.50 AMA PRA Category 1 Credit™
Please login or register to take this course.

This course is offered through Pri-Med. 

 

To take this course you will be redirected to Pri-Med's website. You must login or create an account with Pri-Med in order to complete this activity. 

 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!